Skip to main content

Month: June 2020

Greenlane Launches VIBES Rolling Papers In Europe and Canada

BOCA RATON, Fla., June 08, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of the largest global sellers of premium cannabis accessories and specialty vaporization products, announced today that the popular, ultra high-quality VIBES Rolling Papers are now available in specialty locations throughout Europe and Canada. The brand is a joint venture between Greenlane and San Francisco entrepreneur and rapper Gilbert “Berner” Milam Jr.VIBES first launched in 2019 and quickly gained a strong reputation for producing superior quality papers. Cultivated and crafted in France and then cut and kitted in the Dominican Republic, VIBES papers allow for a slow burn and elevated flavor experience. The collection includes cones and papers made out of natural materials such as hemp and rice as...

Continue reading

Generation Mining Begins Trading on OTCQB Market Under Ticker GENMF

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) — Generation Mining Limited (CSE:GENM) (“Gen Mining”, “Generation”, or the “Company”) is pleased to announce that its common shares are now trading on the OTCQB Venture Marketplace (the “OTCQB Venture”), a US trading platform that is operated by the OTC Markets Group in New York. The Company will trade on the OTCQB Venture under symbol “GENMF”; the Company’s common shares will continue to trade on the CSE under the symbol “GENM”. Nauth LPC acted as the Company’s OTC Markets Sponsor.“Listing on the OTCQB Venture is part of our strategy to introduce the Company to a broader audience,” said Jamie Levy, President of Gen Mining. “We believe trading on the OTCQB will help us to introduce the company and enhance liquidity by providing our...

Continue reading

Decisions of the annual general meeting of QPR Software Plc

QPR SOFTWARE PLC STOCK EXCHANGE BULLETIN 8 JUNE, 2020 AT 2:00 P.M.DECISIONS OF THE ANNUAL GENERAL MEETING OF QPR SOFTWARE PLC AND THE ORGANIZING MEETING OF THE BOARD OF DIRECTORSThe Annual General Meeting held on 8 June, 2020 made the following resolutions:ADOPTION OF THE ANNUAL ACCOUNTS AND RESOLUTION ON THE DISCHARGE FROM LIABILITYThe Annual General Meeting approved the Company’s financial statements and the Group’s financial statements for the financial period of January 1 – December 31, 2019 and discharged the members of the Board of Directors and the CEO from liability.DIVIDENDThe Annual General Meeting approved the Board’s proposal that no dividend be paid for the financial year 2019.REMUNERATION POLICYThe Annual General Meeting made an advisory decision on the Remuneration Policy and decided to support the proposed Remuneration...

Continue reading

QPR Software Oyj:n varsinaisen yhtiökokouksen päätökset

QPR SOFTWARE OYJ PÖRSSITIEDOTE 8.6.2020 KLO 14:00QPR SOFTWARE OYJ:N VARSINAISEN YHTIÖKOKOUKSEN PÄÄTÖKSET JA HALLITUKSEN JÄRJESTÄYTYMISKOKOUSQPR Software Oyj:n varsinaisessa yhtiökokouksessa 8.6.2020 tehtiin seuraavat päätökset:TILINPÄÄTÖKSEN VAHVISTAMINEN, HALLITUKSEN JÄSENTEN JA TOIMITUSJOHTAJAN VASTUUVAPAUSYhtiökokous vahvisti yhtiön tilinpäätöksen konsernitilinpäätöksineen tilikaudelta 1.1.–31.12.2019 sekä myönsi vastuuvapauden hallituksen jäsenille ja toimitusjohtajalle.OSINKOYhtiökokous päätti hallituksen esityksen mukaisesti, että tilikaudelta 2019 ei jaeta osinkoa.PALKITSEMISPOLITIIKKAYhtiökokous teki yhtiön toimielinten palkitsemispolitiikasta neuvoa-antavan päätöksen, ja päätti kannattaa esitettyä palkitsemispolitiikkaa.HALLITUKSEN JÄSENTEN PALKKIOTYhtiökokous päätti pitää hallitustyöskentelystä maksettavat palkkiot ennallaan....

Continue reading

Atlas Technical Consultants to Present at the Stifel 2020 Virtual Cross Sector Insight Conference

AUSTIN, Texas, June 08, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, program management and consulting services, announced today that Joe Boyer, CEO, and David Quinn, CFO, will present at the Stifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10, 2020 at 4:00 p.m. Eastern Time.A live audio webcast will be available at the time of the event and may be accessed through the Investors section of the Company’s website at https://www.oneatlas.com.  A replay of the audio webcast will be available after the event.About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of professional testing, inspection engineering and consulting services under the name Atlas...

Continue reading

Indiva Reports First Quarter Fiscal Year 2020 Results

LONDON, Ontario, June 08, 2020 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce its financial and operating results for first quarter fiscal 2020 ended March 31, 2020. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). For a more comprehensive overview of the corporate and financial highlights presented in this press release, please refer to Indiva’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2020, and the Company’s Condensed Consolidated Interim Financial Statements for the Three Months Ended March 31, 2020 and 2019, which are...

Continue reading

MediPharm Labs Closes $37.8 Million Private Placement

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has today closed a private placement with an institutional investor (the “Investor”), for aggregate gross proceeds of $37,822,500 (the “Offering”). All dollar amounts in this news release are in Canadian dollars.$18,911,250 of the Offering is related to the placement of a $20.5 million unsecured convertible note (the “First Note”) and a warrant (the “First Warrant”) to purchase up to 3,601,427 common shares of the Company (the “Common Shares”); and $18,911,250 of the Offering is currently being held in escrow and is related to the placement...

Continue reading

Influenza Vaccines Market to Rise at 7.7% CAGR till 2026; Increasing Demand for Effective Flu Vaccines to Aid Market Expansion: Fortune Business Insights™

Pune, June 08, 2020 (GLOBE NEWSWIRE) — The global influenza vaccines market size is slated to reach USD 7.34 billion by 2026, exhibiting a CAGR of 7.7% during the forecast period. Increasing prevalence of influenza worldwide will be the major driving force behind the growth of this market. According to the World Health Organization (WHO), around 3 to 5 million cases of influenza-based diseases are reported annually across the globe. This has spurred governments to take proactive measures to contain the spread of this deadly disease.Many governments carry out extensive vaccination drives before the flu season begins to immunize people from contracting any such infections, bolstering the seasonal influenza vaccines market demand. At the global level, organizations such as the WHO and the United Nations’ Children Fund (UNICEF) regularly...

Continue reading

New Study Demonstrates GeneSight Psychotropic Better Predicts Blood Drug Levels When Compared to Single-Gene Testing

SALT LAKE CITY, June 08, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today a newly published study in Psychiatry Research. The study demonstrated the GeneSight® Psychotropic test is better at predicting citalopram and escitalopram blood concentrations when compared to single-gene testing.The GeneSight test uses a combinatorial pharmacogenomic approach, which evaluates how variations in multiple genes may influence an individual’s outcomes with certain medications.“The GeneSight test assesses and weighs multiple gene factors, which more accurately predicts blood drug levels and identifies more patients with significant gene-drug interactions who would be missed by single-gene testing,” said Michael R. Jablonski, Ph.D., vice president of medical...

Continue reading

Barry Eccleston, former President and CEO of Airbus America, named Executive Chairman of FLYHT Aerospace

CALGARY, Alberta, June 08, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today reported that Mr. Barry Eccleston, former President and CEO of Airbus America has agreed to serve as Executive Chairman of the Board of FLYHT and will help guide the Company utilizing his strong relationships with customers, suppliers and OEMs in the commercial aviation and defense industries. Mr. Eccleston has enjoyed a 40+ year storied career as an aerospace visionary and proponent of the advancement and development of the aviation industry. Mr. Bill Tempany, former CEO of FLYHT,  will serve as the interim Chief Executive Officer while the Company recruits a permanent replacement.  Mr. Tempany will also continue to serve as a director of the Company.The Company has terminated the contract...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.